CALA Dividend: Calithera Biosciences Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

CALA Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	0	0	9	0	0	22
Revenue Growth (YoY)	-100%	-100%	--	--	-100%	-12%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	13	13	20	20	16	13
Research & Development	28	28	103	71	76	66
Operating Expenses	42	42	123	91	92	79
Other Non Operating Income (Expenses)	0	0	--	--	--	--
Pretax Income	-39	-39	-115	-90	-89	-54
Income Tax Expense	--	--	--	--	--	--
Net Income	-21	-21	-115	-90	-89	-54
Net Income Growth	-82%	-82%	28%	1%	65%	100%
Shares Outstanding (Diluted)	4.87	4.63	3.69	3.44	2.37	1.83
Shares Change (YoY)	30%	25%	7%	45%	30%	11%
EPS (Diluted)	-4.37	-4.6	-31.18	-26.2	-37.91	-29.85
EPS Growth	-86%	-85%	19%	-31%	27%	77%
Free Cash Flow	-43	-43	-66	-84	-78	-65
Free Cash Flow Per Share	-8.82	-9.28	-17.88	-24.41	-32.91	-35.51
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	-1,266.66%	0%	0%	-259.09%
Profit Margin	0%	0%	-1,277.77%	0%	0%	-245.45%
Free Cash Flow Margin	0%	0%	-733.33%	0%	0%	-295.45%
EBITDA	-42	-42	-114	-91	-92	-57
EBITDA Margin	0%	0%	-1,266.66%	0%	0%	-259.09%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-42	-42	-114	-91	-92	-57
EBIT Margin	0%	0%	-1,266.66%	0%	0%	-259.09%
Effective Tax Rate	--	--	--	--	--	--